静脉血栓栓塞症及其与 COVID-19 的关联：仍存在争议。
Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.
机构信息
UOC Medicina, Fatebenefratelli Hospital of Naples, 34102 Naples, Italy.
Chair of Cardiology, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli"-Monaldi Hospital, Piazzale Ettore Ruggeri, 80131 Naples, Italy.
出版信息
Medicina (Kaunas). 2020 Sep 27;56(10):506. doi: 10.3390/medicina56100506.
Abstract
Asreported by the World Health Organization, a novel coronavirus (COVID-19) was identified as the causative virus of new viral pneumonia of unknown etiology by Chinese authorities on 7 January 2020. The virus was named COVID-19 and because of its ability to cause severe acute respiratory syndrome (i.e., SARS) this infection has also been defined as SARS-CoV2.Furthermore, an association between COVID-19 infection and venous thromboembolism has been reported in several series around the world.For this reason, methods used to improve diagnostic tools, pharmacological thromboprophylaxis and type of anticoagulants are discussed in this expert opinion.
摘要
据世界卫生组织报告，中国当局于 2020 年 1 月 7 日鉴定出一种新型冠状病毒（COVID-19），为不明病因的新型病毒性肺炎的病原体。该病毒被命名为 COVID-19，由于其能够引起严重急性呼吸系统综合征（即 SARS），因此这种感染也被定义为 SARS-CoV2。此外，世界各地的多个系列报道了 COVID-19 感染与静脉血栓栓塞之间的关联。因此，本专家意见中讨论了用于改善诊断工具、药物预防血栓形成和抗凝剂类型的方法。
相似文献
1
Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.
Medicina (Kaunas). 2020 Sep 27;56(10):506. doi: 10.3390/medicina56100506.
2
Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation.
Mayo Clin Proc. 2020 Oct;95(10):2291-2293. doi: 10.1016/j.mayocp.2020.08.014. Epub 2020 Aug 13.
3
Venous thromboembolism in non-critically ill patients with COVID-19 infection.
Thromb Res. 2020 Sep;193:166-169. doi: 10.1016/j.thromres.2020.07.033. Epub 2020 Jul 17.
4
Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society.
Kardiol Pol. 2020 Jun 25;78(6):642-646. doi: 10.33963/KP.15425. Epub 2020 Jun 8.
5
A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.
Br J Hosp Med (Lond). 2020 May 2;81(5):1-2. doi: 10.12968/hmed.2020.0210. Epub 2020 May 18.
6
COVID-19 and venous thromboembolism - prophylaxis and treatment.
Tidsskr Nor Laegeforen. 2020 Jun 17;140(11). doi: 10.4045/tidsskr.20.0440. Print 2020 Aug 18.
7
Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 pandemic.
J Vasc Surg Venous Lymphat Disord. 2020 Jul;8(4):526-534. doi: 10.1016/j.jvsv.2020.04.009. Epub 2020 Apr 17.
8
Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).
Vasa. 2020 Jun;49(4):259-263. doi: 10.1024/0301-1526/a000885. Epub 2020 Jun 5.
9
Venous thromboembolism and COVID-19.
Respir Med Res. 2020 Nov;78:100759. doi: 10.1016/j.resmer.2020.100759. Epub 2020 Apr 28.
10
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.
Lancet Haematol. 2020 May;7(5):e362-e363. doi: 10.1016/S2352-3026(20)30109-5. Epub 2020 Apr 9.
引用本文的文献
1
Exploring the Applicability of Using Natural Language Processing to Support Nationwide Venous Thromboembolism Surveillance: Model Evaluation Study.
JMIR Bioinform Biotechnol. 2022 May 8;3(1):e36877. doi: 10.2196/36877.
2
Thrombotic Disorders and Antithrombotic Treatments Special Issue.
Medicina (Kaunas). 2022 Feb 2;58(2):229. doi: 10.3390/medicina58020229.
3
Remdesivir in Severe COVID-19 and Non-Invasive Ventilation: A Real-Life Experience.
Healthcare (Basel). 2021 Aug 27;9(9):1108. doi: 10.3390/healthcare9091108.
4
Severe COVID-19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis.
Res Pract Thromb Haemost. 2021 Sep 12;5(6):e12582. doi: 10.1002/rth2.12582. eCollection 2021 Aug.
5
The Angiotensin Converting Enzyme Deletion/Deletion Genotype Is a Risk Factor for Severe COVID-19: Implication and Utility for Patients Admitted to Emergency Department.
Medicina (Kaunas). 2021 Aug 20;57(8):844. doi: 10.3390/medicina57080844.
6
Edoxaban for the treatment of pulmonary embolism in hospitalized COVID-19 patients.
Expert Rev Clin Pharmacol. 2021 Oct;14(10):1289-1294. doi: 10.1080/17512433.2021.1964359. Epub 2021 Aug 17.
7
Clinical Differences between COVID-19 and a COVID-Like Syndrome.
J Clin Med. 2021 Jun 7;10(11):2519. doi: 10.3390/jcm10112519.
8
Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis.
Front Med (Lausanne). 2021 Mar 9;8:647917. doi: 10.3389/fmed.2021.647917. eCollection 2021.
9
Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study.
J Blood Med. 2021 Feb 11;12:69-75. doi: 10.2147/JBM.S285214. eCollection 2021.
10
Prognostic Value of Fibrinogen among COVID-19 Patients Admitted to an Emergency Department: An Italian Cohort Study.
J Clin Med. 2020 Dec 21;9(12):4134. doi: 10.3390/jcm9124134.
本文引用的文献
1
Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study.
Pharmacol Res. 2020 Sep;159:104965. doi: 10.1016/j.phrs.2020.104965. Epub 2020 May 29.
2
Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial".
Blood Transfus. 2020 May;18(3):239-240. doi: 10.2450/2020.0116-20.
3
Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial.
Blood Transfus. 2020 May;18(3):237-238. doi: 10.2450/2020.0109-20.
4
Acute Pulmonary Embolism and COVID-19.
Radiology. 2020 Dec;297(3):E335-E338. doi: 10.1148/radiol.2020201955. Epub 2020 May 14.
5
Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort.
J Clin Med. 2020 May 7;9(5):1371. doi: 10.3390/jcm9051371.
6
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
7
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.
8
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.
Thromb Res. 2020 Jul;191:9-14. doi: 10.1016/j.thromres.2020.04.024. Epub 2020 Apr 23.
9
COVID19 coagulopathy in Caucasian patients.
Br J Haematol. 2020 Jun;189(6):1044-1049. doi: 10.1111/bjh.16749. Epub 2020 May 17.
10
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.
Thromb Haemost. 2020 Jun;120(6):998-1000. doi: 10.1055/s-0040-1710018. Epub 2020 Apr 21.
Zotero 插件